{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:18:18Z","timestamp":1771503498643,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12185-019-02725-8","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T08:02:41Z","timestamp":1566201761000},"page":"584-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Essential thrombocytosis attributed to JAK2-T875N germline mutation"],"prefix":"10.1007","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5935-0385","authenticated-orcid":false,"given":"Makoto","family":"Yoshimitsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Hachiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naosuke","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Shide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"issue":"7037","key":"2725_CR1","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434(7037):1144\u20138. \n                    https:\/\/doi.org\/10.1038\/nature03546\n                    \n                  .","journal-title":"Nature"},{"issue":"17","key":"2725_CR2","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352(17):1779\u201390. \n                    https:\/\/doi.org\/10.1056\/NEJMoa051113\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"9464","key":"2725_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054\u201361. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(05)71142-9\n                    \n                  .","journal-title":"Lancet"},{"issue":"25","key":"2725_CR4","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","volume":"369","author":"J Nangalia","year":"2013","unstructured":"Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med. 2013;369(25):2391\u2013405. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1312542\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"25","key":"2725_CR5","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013;369(25):2379\u201390. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1311347\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"2725_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25303","author":"A Tefferi","year":"2018","unstructured":"Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol. 2018. \n                    https:\/\/doi.org\/10.1002\/ajh.25303\n                    \n                  .","journal-title":"Am J Hematol"},{"issue":"6","key":"2725_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s12185-018-2421-7","volume":"107","author":"K Misawa","year":"2018","unstructured":"Misawa K, Yasuda H, Araki M, Ochiai T, Morishita S, Shirane S, et al. Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms. Int J Hematol. 2018;107(6):673\u201380. \n                    https:\/\/doi.org\/10.1007\/s12185-018-2421-7\n                    \n                  .","journal-title":"Int J Hematol"},{"issue":"1","key":"2725_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng0198-49","volume":"18","author":"A Wiestner","year":"1998","unstructured":"Wiestner A, Schlemper RJ, van der Maas AP, Skoda RC. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet. 1998;18(1):49\u201352. \n                    https:\/\/doi.org\/10.1038\/ng0198-49\n                    \n                  .","journal-title":"Nat Genet"},{"issue":"10","key":"2725_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1056\/NEJMc1200349","volume":"366","author":"AJ Mead","year":"2012","unstructured":"Mead AJ, Rugless MJ, Jacobsen SE, Schuh A. Germline JAK2 mutation in a family with hereditary thrombocytosis. N Engl J Med. 2012;366(10):967\u20139. \n                    https:\/\/doi.org\/10.1056\/NEJMc1200349\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"9","key":"2725_CR10","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1182\/blood-2013-05-504555","volume":"123","author":"C Marty","year":"2014","unstructured":"Marty C, Saint-Martin C, Pecquet C, Grosjean S, Saliba J, Mouton C, et al. Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors. Blood. 2014;123(9):1372\u201383. \n                    https:\/\/doi.org\/10.1182\/blood-2013-05-504555\n                    \n                  .","journal-title":"Blood"},{"issue":"7","key":"2725_CR11","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1182\/blood-2012-12-473777","volume":"123","author":"SL Etheridge","year":"2014","unstructured":"Etheridge SL, Cosgrove ME, Sangkhae V, Corbo LM, Roh ME, Seeliger MA, et al. A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis. Blood. 2014;123(7):1059\u201368. \n                    https:\/\/doi.org\/10.1182\/blood-2012-12-473777\n                    \n                  .","journal-title":"Blood"},{"issue":"15","key":"2725_CR12","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1182\/blood-2008-04-149047","volume":"114","author":"J Ding","year":"2009","unstructured":"Ding J, Komatsu H, Iida S, Yano H, Kusumoto S, Inagaki A, et al. The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity. Blood. 2009;114(15):3325\u20138. \n                    https:\/\/doi.org\/10.1182\/blood-2008-04-149047\n                    \n                  .","journal-title":"Blood"},{"issue":"1","key":"2725_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/gt.2011.210","volume":"20","author":"M Scaife","year":"2013","unstructured":"Scaife M, Pacienza N, Au BC, Wang JC, Devine S, Scheid E, et al. Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes. Gene Ther. 2013;20(1):24\u201334. \n                    https:\/\/doi.org\/10.1038\/gt.2011.210\n                    \n                  .","journal-title":"Gene Ther"},{"issue":"48","key":"2725_CR14","doi-asserted-by":"publisher","first-page":"16909","DOI":"10.1073\/pnas.0407572101","volume":"101","author":"M Yoshimitsu","year":"2004","unstructured":"Yoshimitsu M, Sato T, Tao K, Walia JS, Rasaiah VI, Sleep GT, et al. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc Natl Acad Sci USA. 2004;101(48):16909\u201314. \n                    https:\/\/doi.org\/10.1073\/pnas.0407572101\n                    \n                  .","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2725_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.gt.3302839","volume":"14","author":"M Yoshimitsu","year":"2007","unstructured":"Yoshimitsu M, Higuchi K, Ramsubir S, Nonaka T, Rasaiah VI, Siatskas C, et al. Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem\/progenitor cells. Gene Ther. 2007;14(3):256\u201365. \n                    https:\/\/doi.org\/10.1038\/sj.gt.3302839\n                    \n                  .","journal-title":"Gene Ther"},{"issue":"13","key":"2725_CR16","doi-asserted-by":"publisher","first-page":"12621","DOI":"10.1074\/jbc.M408442200","volume":"280","author":"A Numata","year":"2005","unstructured":"Numata A, Shimoda K, Kamezaki K, Haro T, Kakumitsu H, Shide K, et al. Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT\/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. J Biol Chem. 2005;280(13):12621\u20139. \n                    https:\/\/doi.org\/10.1074\/jbc.M408442200\n                    \n                  .","journal-title":"J Biol Chem"},{"issue":"20","key":"2725_CR17","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1182\/blood-2012-05-430926","volume":"121","author":"AJ Mead","year":"2013","unstructured":"Mead AJ, Chowdhury O, Pecquet C, Dusa A, Woll P, Atkinson D, et al. Impact of isolated germline JAK2V617I mutation on human hematopoiesis. Blood. 2013;121(20):4156\u201365. \n                    https:\/\/doi.org\/10.1182\/blood-2012-05-430926\n                    \n                  .","journal-title":"Blood"},{"issue":"7","key":"2725_CR18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.febslet.2011.02.032","volume":"585","author":"H Zou","year":"2011","unstructured":"Zou H, Yan D, Mohi G. Differential biological activity of disease-associated JAK2 mutants. FEBS Lett. 2011;585(7):1007\u201313. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2011.02.032\n                    \n                  .","journal-title":"FEBS Lett"},{"issue":"52","key":"2725_CR19","doi-asserted-by":"publisher","first-page":"18962","DOI":"10.1073\/pnas.0509714102","volume":"102","author":"X Lu","year":"2005","unstructured":"Lu X, Levine R, Tong W, Wernig G, Pikman Y, Zarnegar S, et al. Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. Proc Natl Acad Sci USA. 2005;102(52):18962\u20137. \n                    https:\/\/doi.org\/10.1073\/pnas.0509714102\n                    \n                  .","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2725_CR20","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","volume":"107","author":"G Wernig","year":"2006","unstructured":"Wernig G, Mercher T, Okabe R, Levine RL, Lee BH, Gilliland DG. Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood. 2006;107(11):4274\u201381. \n                    https:\/\/doi.org\/10.1182\/blood-2005-12-4824\n                    \n                  .","journal-title":"Blood"},{"issue":"8","key":"2725_CR21","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1182\/blood-2006-04-014712","volume":"108","author":"T Mercher","year":"2006","unstructured":"Mercher T, Wernig G, Moore SA, Levine RL, Gu TL, Frohling S, et al. JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model. Blood. 2006;108(8):2770\u20139. \n                    https:\/\/doi.org\/10.1182\/blood-2006-04-014712\n                    \n                  .","journal-title":"Blood"},{"issue":"4","key":"2725_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1006\/jmcc.1998.0639","volume":"30","author":"CD McWhinney","year":"1998","unstructured":"McWhinney CD, Dostal D, Baker K. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. J Mol Cell Cardiol. 1998;30(4):751\u201361. \n                    https:\/\/doi.org\/10.1006\/jmcc.1998.0639\n                    \n                  .","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2725_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/cvr\/cvr059","volume":"91","author":"A Kirabo","year":"2011","unstructured":"Kirabo A, Kearns PN, Jarajapu YP, Sasser JM, Oh SP, Grant MB, et al. Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species. Cardiovasc Res. 2011;91(1):171\u20139. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvr059\n                    \n                  .","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2725_CR24","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1084\/jem.20160412","volume":"214","author":"D Sun","year":"2017","unstructured":"Sun D, Moore S, Jakobs TC. Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries. J Exp Med. 2017;214(5):1411\u201330. \n                    https:\/\/doi.org\/10.1084\/jem.20160412\n                    \n                  .","journal-title":"J Exp Med"},{"issue":"3","key":"2725_CR25","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1007\/s12035-014-8945-9","volume":"52","author":"M Wong","year":"2015","unstructured":"Wong M, Li Y, Li S, Zhang S, Li W, Zhang P, et al. Therapeutic retrobulbar inhibition of STAT3 protects ischemic retina ganglion cells. Mol Neurobiol. 2015;52(3):1364\u201377. \n                    https:\/\/doi.org\/10.1007\/s12035-014-8945-9\n                    \n                  .","journal-title":"Mol Neurobiol"},{"issue":"8","key":"2725_CR26","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1167\/iovs.09-4864","volume":"51","author":"DY Wang","year":"2010","unstructured":"Wang DY, Ray A, Rodgers K, Ergorul C, Hyman BT, Huang W, et al. Global gene expression changes in rat retinal ganglion cells in experimental glaucoma. Investig Ophthalmol Vis Sci. 2010;51(8):4084\u201395. \n                    https:\/\/doi.org\/10.1167\/iovs.09-4864\n                    \n                  .","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"2725_CR27","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1167\/iovs.07-0542","volume":"48","author":"Z Yang","year":"2007","unstructured":"Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, Valenta D, et al. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Investig Ophthalmol Vis Sci. 2007;48(12):5539\u201348. \n                    https:\/\/doi.org\/10.1167\/iovs.07-0542\n                    \n                  .","journal-title":"Investig Ophthalmol Vis Sci."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02725-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02725-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02725-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T23:45:12Z","timestamp":1597707912000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02725-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2725"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02725-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"26 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}